Dominique Costagliola
Inserm UMR S 1136 Université Pierre et Marie Curie Epidémiologie, stratégies thérapeutiques et virologie cliniques dans l'infection à VIH, Paris, France · INSERM U943 · Inserm U943
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
15
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
86
PubMed author-name match
Trials
Studies that name Dominique Costagliola as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02212379 · Capacity of the Dual Combination Raltegravir/Etravirine to Maintain Virological Success in HIV-1 Infected Patients of at Least 45 Years of Age- ANRS 163 ETRALANRS, Emerging Infectious Diseases · completed · HIV-1 Infection · study director
- Ph3NCT01453192 · Renal Transplantation and Raltegravir in HIV-Infected PatientsANRS, Emerging Infectious Diseases · completed · HIV-1 Infection, Chronic Renal Insufficiency · study director
- Ph2NCT01420523 · Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With LipohypertrophyANRS, Emerging Infectious Diseases · terminated · Human Immunodeficiency Virus, Lipohypertrophy · study director
- Ph3NCT01348308 · Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected PatientsANRS, Emerging Infectious Diseases · completed · HIV-1 Infection, AIDS · study director
- Ph2NCT01282047 · Lenalidomide in Kaposi Disease Associated With HIV InfectionFrench National Agency for Research on AIDS and Viral Hepatitis · terminated · HIV Infection Associated Kaposi Disease · study director
- Ph3NCT00148850 · Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 PatientsFrench National Agency for Research on AIDS and Viral Hepatitis · terminated · HIV-Associated Lipodystrophy Syndrome, HIV Infections · study chair
- Ph2NCT00126243 · Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaFrench National Agency for Research on AIDS and Viral Hepatitis · terminated · AIDS Related Lymphoma · study chair
- Ph3NCT00125814 · Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral SuppressionFrench National Agency for Research on AIDS and Viral Hepatitis · terminated · HIV Infections · study chair
- Ph4NCT00122668 · Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive PatientsFrench National Agency for Research on AIDS and Viral Hepatitis · terminated · HIV Infections, HIV-Associated Lipodystrophy Syndrome · study chair
- Ph4NCT00122655 · Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With LipoatrophyFrench National Agency for Research on AIDS and Viral Hepatitis · terminated · HIV Infections, HIV Lipodystrophy Syndrome · study chair
- Ph3NCT00120757 · Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)French National Agency for Research on AIDS and Viral Hepatitis · completed · Osteoporosis, HIV Infections · study chair
- Ph2NCT00120783 · Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug ResistanceFrench National Agency for Research on AIDS and Viral Hepatitis · terminated · HIV Infections · study chair
- Ph2NCT00120367 · Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)French National Agency for Research on AIDS and Viral Hepatitis · completed · Leukoencephalopathy, Progressive Multifocal, HIV Infections · study chair
- Ph3NCT00118677 · Long-Term Supervised Treatment Interruption in HIV-Infected PatientsFrench National Agency for Research on AIDS and Viral Hepatitis · completed · HIV Infections · study chair
- Ph4NCT00117494 · Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)French National Agency for Research on AIDS and Viral Hepatitis · completed · Hyperlipidemia, HIV Infections · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:54 UTC. The ranking covers the 200 most relevant of 86 PubMed records, and a shared surname and initials can bring in a namesake. All 86 on PubMed
- Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.Lancet Infect Dis · 2022265 citationsRCR 17.7
- 201 citationsRCR 6.1
- 175 citationsRCR 4.2
- Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design.Lancet Infect Dis · 2024174 citationsRCR 35.7
- 157 citationsRCR 4.0
- Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.J Clin Oncol · 2006153 citationsRCR 3.6
- Insulinemic and glycemic indexes of six starch-rich foods taken alone and in a mixed meal by type 2 diabetics.Am J Clin Nutr · 1987133 citationsRCR 5.6
- A therapeutic dendritic cell-based vaccine for HIV-1 infection.J Infect Dis · 2011105 citationsRCR 2.5
- Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.Antimicrob Agents Chemother · 200394 citationsRCR 2.5
- 92 citationsRCR 4.6